| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.38 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |